Veloxis Pharmaceuticals Announces Initiation of STRATO Study of LCP-Tacro™ in ... PR-CANADA.net (press release) The STRATO study is designed to explore whether a conversion of patients who have symptomatic tremor from treatment with standard immediate release twice-daily tacrolimus capsules to extended release once-daily LCP-Tacro™ tablets leads to a measurable ... |
